Ionis Pharmaceuticals reiterates FY26 outlook, unchanged from April projections
Seeking Alpha ·
Ionis Pharmaceuticals (IONS) has reiterated its previously issued financial outlook for the full fiscal year ending December 31, 2026. The corporate guidance remains entirely unchanged from the financial projections originally provided by the company on
DYAX Investor Sentiment
Bullish (Long) 73% · Bearish (Short) 27%
409 participants
Related News
- Toll Brothers upgraded to Buy at Citi on K-shaped recovery
- GSK partner Hansoh posts late-stage trial win for lung cancer drug in China
- WisdomTree reports $160.9B June AUM, nearly $9B of YTD net inflows
- At a glance: stocks gapping down premarket
- Uh-Oh! The Fed Just Singled Out a New Inflationary Pressure, and It's Awful News for Wall Street.
- Tech firms must ‘stamp out’ scam adverts or face fines, under Ofcom proposals